BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers

British Journal of Cancer

Volumn 101, Issue 3, 2009, Pages 504-510

  Lee, Y K ^a   Choi, E ^a   Kim, M A ^a   Park, P G ^a   Park, N H ^a   Lee, H ^a  

^a Seoul National University   (South Korea)

Author keywords

Aurora A; BubR1; Ovarian neoplasm; Prognosis; Recurrence free survival

Indexed keywords

BUB1 RELATED PROTEIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE MARKER; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE RISK; SURVIVAL RATE;

CHROMOSOMAL INSTABILITY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SURVIVAL RATE;

EID: 68149164763     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605161     Document Type: Article

References (48)

1. Abrieu A, Kahana JA, Wood KW, Cleveland DW (2000) CENP-E as an essential component of the mitotic checkpoint in vitro. Cell 102: 817-826
2. Amon A (1999) The spindle checkpoint. Curr Opin Genet Dev 9: 69-75
3. Anand S, Penrhyn-Lowe S, Venkitaraman AR (2003) AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3: 51-62
4. Berdnik D, Knoblich JA (2002) Drosophila Aurora-A is required for centrosome maturation and actin-dependent asymmetric protein localization during mitosis. Curr Biol 12: 640-647
5. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ, Plowman GD (1998) A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 17: 3052-3065
6. Burum-Auensen E, De Angelis PM, Schjolberg AR, Kravik KL, Aure M, Clausen OP (2007a) Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry. J Histochem Cytochem 55: 477-486
7. Burum-Auensen E, Deangelis PM, Schjolberg AR, Roislien J, Andersen SN, Clausen OP (2007b) Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis. J Clin Pathol 60: 1403-1408
8. But I, Gorisek B (2000) DNA-ploidy as an independent prognostic factor in patients with serous ovarian carcinoma. Int J Gynaecol Obstet 71: 259-262
9. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392: 300-303
10. Chan GK, Yen TJ (2003) The mitotic checkpoint: a signaling pathway that allows a single unattached kinetochore to inhibit mitotic exit. Prog Cell cycle Res 5: 431-439
11. Choi E, Choe H, Min J, Choi JY, Kim J, Lee H (2009) BubR1 acetylation at prometaphase is required for modulating APC/C activity and timing of mitosis. EMBO J e-pub ahead 30 April 2009; doi:10.1038/emboj.2009.123
12. Chi YH, Jeang KT (2007) Aneuploidy and cancer. J Cell Biochem 102: 531-538
13. Elowe S, Hummer S, Uldschmid A, Li X, Nigg EA (2007) Tension-sensitive Plk1 phosphorylation on BubR1 regulates the stability of kinetochore microtubule interactions. Genes Dev 21: 2205-2219
14. Friedlander ML (1998) Prognostic factors in ovarian cancer. Semin Oncol 25: 305-314
15. Fu Y, Ye D, Chen H, Lu W, Ye F, Xie X (2007) Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30. Gynecol Oncol 105: 66-73
16. Giet R, Petretti C, Prigent C (2005) Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol 15: 241-250
17. Gorringe KL, Chin SF, Pharoah P, Staines JM, Oliveira C, Edwards PA, Caldas C (2005) Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer. Carcinogenesis 26: 923-930
18. Grabsch H, Takeno S, Parsons WJ, Pomjanski N, Boecking A, Gabbert HE, Mueller W (2003) Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer - association with tumour cell proliferation. J Pathol 200: 16-22
19. Hannak E, Kirkham M, Hyman AA, Oegema K (2001) Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans. J Cell Biol 155: 1109-1116
20. Haruki N, Saito H, Harano T, Nomoto S, Takahashi T, Osada H, Fujii Y (2001) Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers. Cancer Lett 162: 201-205
21. Hernando E, Orlow I, Liberal V, Nohales G, Benezra R, Cordon-Cardo C (2001) Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. Int J Cancer 95: 223-227
22. Imai Y, Shiratori Y, Kato N, Inoue T, Omata M (1999) Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers. Jpn J Cancer Res 90: 837-840
23. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66
24. Kristensen GB, Trope C (1997) Epithelial ovarian carcinoma. Lancet 349: 113-117
25. Lampson MA, Kapoor TM (2005) The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat Cell Biol 7: 93-98
26. Langerod A, Stromberg M, Chin K, Kristensen VN, Borresen-Dale AL (2003) BUB1 infrequently mutated in human breast carcinomas. Hum Mutat 22: 420
27. Lee EA, Keutmann MK, Dowling ML, Harris E, Chan G, Kao GD (2004) Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells. Mol Cancer Ther 3: 661-669
28. Lee H, Trainer AH, Friedman LS, Thistlethwaite FC, Evans MJ, Ponder BA, Venkitaraman AR (1999) Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2. Mol Cell 4: 1-10
29. Myrie KA, Percy MJ, Azim JN, Neeley CK, Petty EM (2000) Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. Cancer Lett 152: 193-199
30. Nigg EA (2002) Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2: 815-825
31. Nigg EA (2006) Origins and consequences of centrosome aberrations in human cancers. Int J Cancer 119: 2717-2723
32. NIH consensus conference (1995) Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA 273: 491-497
33. Olesen SH, Thykjaer T, Orntoft TF (2001) Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity. Carcinogenesis 22: 813-815
34. Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR (1998) Involvement of Brca2 in DNA repair. Mol Cell 1: 347-357
35. Pinto M, Vieira J, Ribeiro FR, Soares MJ, Henrique R, Oliveira J, Jeronimo C, Teixeira MR (2008) Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas. Cell Oncol 30: 389-395
36. Sen S (2000) Aneuploidy and cancer. Curr Opin Oncol 12: 82-88
37. Sen S, Katayama H, Sasai K (2008) Functional significance of Aurora kinase A in centrosome amplification and genomic instability. Adv Exp Med Biol 617: 99-108
38. Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC, Katz RL, Brinkley W, Czerniak B (2002) Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 94: 1320-1329
39. Shichiri M, Yoshinaga K, Hisatomi H, Sugihara K, Hirata Y (2002) Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res 62: 13-17
40. Shin HJ, Baek KH, Jeon AH, Park MT, Lee SJ, Kang CM, Lee HS, Yoo SH, Chung DH, Sung YC, McKeon F, Lee CW (2003) Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell 4: 483-497
41. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast Jr RC., James CD, Couch FJ, Hartmann LC, Lillie J, Smith DI (2001) Genetic analysis of early-versus late-stage ovarian tumors. Cancer Res 61: 5895-5904
42. Tang Z, Bharadwaj R, Li B, Yu H (2001) Mad2-independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1. Dev Cell 1: 227-237
43. Tong T, Zhong Y, Kong J, Dong L, Song Y, Fu M, Liu Z, Wang M, Guo L, Lu S, Wu M, Zhan Q (2004) Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin Cancer Res 10: 7304-7310
44. Yamamoto Y, Matsuyama H, Chochi Y, Okuda M, Kawauchi S, Inoue R, Furuya T, Oga A, Naito K, Sasaki K (2007) Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genet Cytogenet 174: 42-47
45. Yu H (2002) Regulation of APC-Cdc20 by the spindle checkpoint. Curr Opin Cell Biol 14: 706-714
46. Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon DS, Wersto RP, Tully E, Wilsbach K, Gabrielson E (2006) Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res 12: 405-410
47. Zhang D, Hirota T, Marumoto T, Shimizu M, Kunitoku N, Sasayama T, Arima Y, Feng L, Suzuki M, Takeya M, Saya H (2004) Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene 23: 8720-8730
48. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S (1998) Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20: 189-193